Author: Healthcare Propulsion Staff

Compassion, trust and person-centerd care must be at the heart of supporting people experiencing suicidal distress, according to a leading Adelaide University suicide prevention expert. Speaking on World Suicide Prevention Day, Adelaide University Professor Nicholas Procter said understanding the impact of trauma is vital to helping health professionals provide safer and more meaningful support to people experiencing suicidal distress. As Chair of the National Suicide Prevention Office Advisory Board, Prof Procter has worked in suicide prevention for around 30 years, with a particular focus on safety planning, trauma-informed practice and person-centerd approaches to care. “Trauma can fundamentally shape how a…

The Canon RF 20mm f/1.4L VCM is an intriguing lens for photographers who want a wide field of view without sacrificing aperture. Its f/1.4 maximum aperture makes it particularly appealing for astrophotography, while the 20mm focal length offers plenty of room for landscapes, architecture and other wide-view scenes.We took the lens out to the dark skies of Wales to photograph the night sky and the Perseids, giving it a real-world test in some of the best conditions we could find.With a premium L-series build and a price tag to match, there’s a lot to consider before adding this lens to…

Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England have shown that measuring proteins in the blood can provide important additional clues about the effects of genetic variants, helping to identify diagnoses and potential new disease-causing genes that genome sequencing alone has been unable to resolve. The study analyzed blood samples from people with rare diseases who remained without a genetic diagnosis following analysis through Genomics England’s 100,000 Genomes Project. By measuring nearly 1,500 proteins in blood and combining this information with genomic data, the researchers were able to resolve previously…

Efforts to prevent dementia may be placing too much responsibility on people’s choices while overlooking the wider social and environmental conditions that shape brain health, according to new Curtin University research published in The Lancet Public Health. Researchers mapped 61 potentially modifiable dementia risk and protective factors to assess whether prevention efforts are overlooking the broader social, environmental and policy influences that shape lifelong brain health. The study revealed a strong emphasis on factors addressed through individual motivation and behavior change, despite many dementia risks being influenced by conditions beyond a person’s direct control. Researchers found far less attention is…

Semaglutide, a medication widely used for type 2 diabetes and weight loss, may also provide an unexpected benefit for people with asthma. New research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain, found that semaglutide use was associated with a reduction in asthma attacks of nearly 40%. The study was led by Professor Chloe Bloom, Clinical Associate Professor in Respiratory Epidemiology at the National Heart & Lung Institute, Imperial College London, UK, and presented by Dr. Bohee Lee. Exploring GLP 1 Drugs and Lung Health Dr. Bloom said: “GLP-1 receptor agonists are widely used to treat type…

Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the commercial launch of its In Vitro Diagnostic Regulation (IVDR)-certified Yourgene® Insight DPYD assay, expanding the Company’s clinical genetics portfolio across regulated European markets. The launch follows the successful introduction of the Yourgene Insight DPYD assay as a Research Use Only (RUO) product in May 2026 and marks the completion of the assay’s regulatory transition to full compliance with the European Union’s IVDR. The Yourgene Insight DPYD assay enables the accurate detection of 19 clinically relevant variants in the…

Taking Tylenol or generic acetaminophen during pregnancy may be associated with changes in female reproductive organ development, researchers said, while stressing that their findings do not establish a causal link or suggest future fertility problems. Whether the differences observed in ​the Danish study of infants have implications for fertility later in life and age at menopause will require ​long-term ⁠follow-up, study leader Margit Bistrup Fischer of Rigshospitalet in Copenhagen said in a statement. Women who during pregnancy used the medicine, typically sold generically as paracetamol in Europe, should not be alarmed by the findings, Fischer said. The generic version of…

Nearly half of health boards in England are deliberately delaying care for patients by imposing minimum waiting times in an attempt to manage demand and control costs, reveals exclusive data published by The BMJ today. A total of 17 of the 36 Integrated Care Boards (ICBs) – responsible for planning health services for their local population – have introduced minimum waits of between 12 and 16 weeks for procedures including hip, knee and cataract surgery. The Royal College of Surgeons (RCS) said it was “concerned by the scale” of measures that can prolong patients’ pain, while the Royal College of…

The Lindsay Clancy trial is leaving us all with questions about what postpartum psychosis really is. J_art/Getty Images hide caption toggle caption J_art/Getty Images The trial around Lindsay Clancy may be over for now, but it still leaves us with questions. On today’s episode, we talk to psychiatrists and patients to answer them: What is postpartum psychosis, exactly? Why don’t we know more about it? And what can you do if you are worried about a postpartum loved one? e know more about it? And what can you do if you are worried about a postpartum loved one? Interested in…

Sign up to see the future, today Can’t-miss innovations from the bleeding edge of science and tech These days, large language models are pushing the line between schizophrenic break and reality closer than ever before. In a wild new post that’s going viral on X-formerly-Twitter, an enterprising young biochemist named Douglas Yao showcased a new drug he’s been developing with the aid of ChatGPT. He’s not employed by any pharma company, and his drug lab is setup on a couple folding tables in his garage. Specifically, Yao enthuses about a new drug he calls “PAC-3310,” which he says is meant…